Skip to main content

Table 1 Characteristics and quality evaluation of the included studies

From: Relationship between the upregulation of Notch1 signaling and the clinical characteristics of patients with papillary thyroid carcinoma in East Asia: a systematic review and meta-analysis

Study (year)

Case (n)

Country

Antibody for Notch1

NOS score

H. Fu (2016) [20]

68

China

Cell Signaling Technology, USA

7.5

H.S. Park (2012) [22]

174

South Korea

Abcam, UK

8.5

J. Zhang (2014) [23]

70

China

Epitomics, USA

6

Q. Long (2012) [24]

40

China

Santa Cruz, USA

6.5

M. Jing-You (2017) [25]

69

China

Boosen Biotechnology, CHN

7

  1. Antibody for Notch1: Manufacturer of Notch1 primary antibody
  2. NOS score Newcastle–Ottawa scale score